My team and I set out to test whether GLP-1 drugs — medications like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), originally developed for diabetes and then approved for ...
Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and ...
Aaron Arman, Superintendent Pharmacist at CheqUp, has shared the things you should consider when starting weight loss jabs ...
An independent informational overview of MEDVi's compounded tirzepatide telehealth program, including regulatory ...
Weight loss medications, such as Ozempic or Wegovy, are already impacting sales and prompting companies to roll out smaller portions and more offerings with protein and fiber.
Obesity dipped in Minnesota as GLP‑1 use rose. Experts warn the long‑term picture and who pays are still unsettled.
Opinion
Treatment with GLP-1 drugs must not replace obesity prevention in low and middle income countries
Prevention policies and budgets must be protected and aligned with the expansion of GLP-1 weight loss drugs, argue Kent Buse and colleagues The World Obesity Federation has welcomed the World Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results